Correction: Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)

• Junice Yi Siu Ng,
• Ivan John Clement,
• Cecilia Jimeno,
• Rosa Allyn Sy,
• Roberto Mirasol,
• Pepito De La Pena,
• Araceli Panelo,
• Rima Tan,
• Melanie Santillan,
• Dana Bayani,
• Erik Wiebols

Affiliations

Junice Yi Siu Ng

Real-World Insights, IQVIA, Asia-Pacific, Singapore

Ivan John Clement

Real-World Insights, IQVIA, Asia-Pacific, Singapore

Cecilia Jimeno

Department of Pharmacology and Toxicology, University of the Philippines Manila College of Medicine, Manila, Metro Manila, Philippines

Rosa Allyn Sy

Section of Endocrinology, Diabetes, Metabolism and Nutrition, Ospital Ng Makati, Makati, Metro Manila, Philippines

Roberto Mirasol

Section of Endocrinology, Diabetes and Metabolism, St. Luke’s Medical Center, Quezon City, Metro Manila, Philippines

Pepito De La Pena

Division of Internal Medicine, National Kidney and Transplant Institute, Quezon City, National Capital Region, Philippines

Araceli Panelo

Department of Medicine, University of the East, Ramon Magasaysay Memorial Medical Center, Quezon City, Metro Manila, Philippines

Rima Tan

Institute for Studies on Diabetes Foundation Inc, Marikina City, Metro Manila, Philippines

Melanie Santillan

Benefits Development and Research Department, Philippine Health Insurance Corporation, Manila, Metro Manila, Philippines

Dana Bayani

Department of Health, Health Research Division, Health Policy Development and Planning Bureau, Manila, Metro Manila, Philippines

Erik Wiebols

Market Access, Health Economics, and Public Affairs, Novo Nordisk Region Southeast Asia, Kuala Lumpur, Malaysia